These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8160532)

  • 1. Pulsatile fluctuations of plasma-gonadotropin-releasing hormone and corticotropin-releasing factor levels in healthy pregnant women.
    Petraglia F; Genazzani AD; Aguzzoli L; Gallinelli A; de Vita D; Caruso A; Genazzani AR
    Acta Obstet Gynecol Scand; 1994 Apr; 73(4):284-9. PubMed ID: 8160532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The maternal hypothalamic-pituitary-adrenal axis in the third trimester of human pregnancy.
    Magiakou MA; Mastorakos G; Rabin D; Margioris AN; Dubbert B; Calogero AE; Tsigos C; Munson PJ; Chrousos GP
    Clin Endocrinol (Oxf); 1996 Apr; 44(4):419-28. PubMed ID: 8706308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating maternal corticotropin-releasing hormone and gonadotropin-releasing hormone in normal and abnormal pregnancies.
    Sorem KA; Smikle CB; Spencer DK; Yoder BA; Graveson MA; Siler-Khodr TM
    Am J Obstet Gynecol; 1996 Oct; 175(4 Pt 1):912-6. PubMed ID: 8885747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoreactive corticotropin-releasing factor and corticotropin during pregnancy, labor and puerperium.
    Laatikainen T; Virtanen T; Räisänen I; Salminen K
    Neuropeptides; 1987; 10(4):343-53. PubMed ID: 2829052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins.
    Apter D; Bützow TL; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactive corticotropin-releasing factor is present in human maternal plasma during the third trimester of pregnancy.
    Sasaki A; Liotta AS; Luckey MM; Margioris AN; Suda T; Krieger DT
    J Clin Endocrinol Metab; 1984 Oct; 59(4):812-4. PubMed ID: 6332823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in amniotic fluid immunoreactive corticotropin-releasing factor (CRF) and CRF-binding protein levels in pregnant women at term and during labor.
    Florio P; Woods RJ; Genazzani AR; Lowry PJ; Petraglia F
    J Clin Endocrinol Metab; 1997 Mar; 82(3):835-8. PubMed ID: 9062492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of corticotropin-releasing factor (CRF) are inversely correlated with low levels of maternal CRF-binding protein in pregnant women with pregnancy-induced hypertension.
    Petraglia F; Florio P; Benedetto C; Gallo C; Woods RJ; Genazzani AR; Lowry PJ
    J Clin Endocrinol Metab; 1996 Feb; 81(2):852-6. PubMed ID: 8636316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma corticotrophin-releasing factor (CRF) in normal pregnancy.
    Wolfe CD; Patel SP; Campbell EA; Linton EA; Anderson J; Lowry PJ; Jones MT
    Br J Obstet Gynaecol; 1988 Oct; 95(10):997-1002. PubMed ID: 3263881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal corticotropin-releasing hormone levels in the early third trimester predict length of gestation in human pregnancy.
    Wadhwa PD; Porto M; Garite TJ; Chicz-DeMet A; Sandman CA
    Am J Obstet Gynecol; 1998 Oct; 179(4):1079-85. PubMed ID: 9790402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotrophin-releasing factor immunostaining is present in placenta and fetal membranes from the first trimester onwards and is not affected by labour or administration of mifepristone.
    Cooper ES; Brooks AN; Miller MR; Greer IA
    Clin Endocrinol (Oxf); 1994 Nov; 41(5):677-83. PubMed ID: 7828359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in gonadotropin-releasing hormone (GnRH) pulse frequency with aging in postmenopausal women.
    Hall JE; Lavoie HB; Marsh EE; Martin KA
    J Clin Endocrinol Metab; 2000 May; 85(5):1794-800. PubMed ID: 10843154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of excessive GnRH-binding substance on circulating maternal hCG in human pregnancy.
    Siler-Khodr TM; Smikle CB; Sorem KA; Grayson MA; Spencer DK; Yoder BA; Khodr GS
    Early Pregnancy; 1997 Mar; 3(1):10-4. PubMed ID: 9265553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corticotropin-releasing factor and gonadotropin-releasing hormone pulse generator activity in the rhesus monkey. Electrophysiological studies.
    Williams CL; Nishihara M; Thalabard JC; Grosser PM; Hotchkiss J; Knobil E
    Neuroendocrinology; 1990 Aug; 52(2):133-7. PubMed ID: 2125701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoreactive corticotropin-releasing hormone in human plasma during pregnancy, labor, and delivery.
    Sasaki A; Shinkawa O; Margioris AN; Liotta AS; Sato S; Murakami O; Go M; Shimizu Y; Hanew K; Yoshinaga K
    J Clin Endocrinol Metab; 1987 Feb; 64(2):224-9. PubMed ID: 3491832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A specific carrier substance for human corticotrophin releasing factor in late gestational maternal plasma which could mask the ACTH-releasing activity.
    Linton EA; Wolfe CD; Behan DP; Lowry PJ
    Clin Endocrinol (Oxf); 1988 Mar; 28(3):315-24. PubMed ID: 2844451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B; Young J; Brailly S; Chanson P; Schaison G
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically active corticotropin-releasing hormone in maternal and fetal plasma during pregnancy.
    Goland RS; Wardlaw SL; Blum M; Tropper PJ; Stark RI
    Am J Obstet Gynecol; 1988 Oct; 159(4):884-90. PubMed ID: 2845784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone increases serum human chorionic gonadotropin in pregnant women.
    Iwashita M; Kudo Y; Shinozaki Y; Takeda Y
    Endocr J; 1993 Oct; 40(5):539-44. PubMed ID: 7951519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian rhythm of plasma testosterone in men with idiopathic hypogonadotrophic hypogonadism before and during pulsatile administration of gonadotrophin-releasing hormone.
    Simoni M; Montanini V; Fustini MF; Del Rio G; Cioni K; Marrama P
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):29-34. PubMed ID: 1559297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.